Navigation Links
Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
Date:1/16/2017

NASHVILLE, Tenn., Jan. 16, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased to announce the addition of Kenneth J. Krogulski, CFA to its Board of Directors. He is the President and Chief Executive Officer of Berkshire Asset Management LLC. He is also the Chief Investment Officer of Berkshire, a 30-year-old independent SEC registered investment advisory firm with over $1.5 billion under management.

Mr. Krogulski has over 37 years' experience in security analysis and portfolio management. He began his career in finance at First Eastern Bank (now PNC Financial) as an investment analysis and portfolio manager. He then served as senior portfolio manager in First Easter's Trust department. Mr. Krogulski then joined Berkshire and later led a management buy-out acquiring the company from Legg Mason. Under his leadership, Berkshire's assets under supervision have grown from $600 million in 2006 and are now over $1.5 billion.

He earned his B.S. in finance from Indiana University of Pennsylvania and his M.B.A from Wilkes University. He holds the Chartered Financial Analysts designation.

"Ken adds a new perspective to our Board, given his role and experience as an investor and portfolio manager," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "We look forward to working with him as we seek to elevate Cumberland's public company profile."

"I am impressed with Cumberland's proven management team, strong fundamentals and growing portfolio of specialty branded pharmaceuticals," said Ken Krogulski. "I look forward to working with the team at Cumberland to advance the Company's mission of enhancing patient care, while also building significant shareholder value."

Mr. Krogulski's appointment to Cumberland's Board as an independent director will be effective January 18, 2017. Cumberland's Board of Directors also includes Joey Jacobs, Chairman and CEO of Acadia Healthcare, Dr. Gordon Bernard, Associate Vice-Chancellor for Research atVanderbilt University Medical Center, Jamie Jones, former Managing Partner of KPMG LLP's Middle Tennessee operations, Thomas Lawrence, Chairman of Aetos Technologies, Jon Griggs, Former Vice President at Warner-Lambert Company, and Caroline Young, former President of the Nashville Healthcare Council, who also all serve as independent directors.

About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on acquisition, development, and commercialization of high-quality products that improve the quality of care for patients. The Company has a diverse product portfolio with a focus in the areas of hospital acute care and gastroenterology.

Cumberland's marketed products include Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, Kristalose® (lactulose) for Oral Solution, a prescription laxative, Vaprisol® (conivaptan) Injection, for the treatment of hyponatremia, Omeclamox-Pak® for the treatment of H. pylori and duodenal ulcer disease, and Ethyol® (amifostine) for Injection, for the prevention of treatment-related adverse reactions in oncology patients.  Cumberland is also dedicated to developing innovative products that address unmet medical needs.

The Company's product candidates in clinical development include: Hepatoren® (ifetroban) Injection for the treatment of hepatorenal syndrome, Boxaban® (ifetroban) Oral Capsule for patients suffering from aspirin exacerbated respiratory disease, VasculanTM (ifetroban) Oral Capsule for the treatment of systemic sclerosis and Portaban™ (ifetroban) Oral Capsule for the treatment of portal hypertension.

For more information on Cumberland Pharmaceuticals Inc., please visit www.cumberlandpharma.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-announces-kenneth-j-krogulski-to-join-its-board-of-directors-300391018.html


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2015 Financial Results
2. Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2015 Financial Results
3. Piramal Critical Care And Cumberland Pharmaceuticals Announce Launch Of Caldolor And Vaprisol Co-Promotion
4. Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing
5. Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com December 3
6. Cumberland Pharmaceuticals And Piramal Enterprises Announce Co-Promotion Agreement
7. Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2015 Financial Results
8. Cumberland Pharmaceuticals To Announce Third Quarter 2015 Financial Results
9. Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10
10. Cumberland Pharmaceuticals To Announce Second Quarter 2015 Financial Results
11. Cumberland Pharmaceuticals Reports First Quarter 2015 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/3/2020)... ... 03, 2020 , ... In Partnership with the Smiles for Everyone Foundation ... at its Burleson, TX office on February 8th. , Dental services provided include same-day ... and extractions . For more information, please visit the Monarch Dental website ...
(Date:1/3/2020)... ... 03, 2020 , ... American actor, Laurence Fishburne, is well-known for his performances ... most know him for the movies he takes part in, he is also the ... explores a vast range of topics to educate its viewers about many issues taking ...
(Date:12/31/2019)... ... December 31, 2019 , ... ... to its Scientific Advisory Board. NanoFUSE Biologics offers a biologically enhanced synthetic therapeutic, ... medical device. , President of NanoFUSE Biologics, Jake Lubinski, said, “We’re fortunate to ...
Breaking Medicine Technology:
(Date:1/10/2020)... ... 2020 , ... Sigma Theta Tau International Honor Society of Nursing (Sigma) was ... awards are regarded as one of the most important and prestigious designations of excellence ... Year competition has recognized Sigma for the last 11 consecutive years. , The following ...
(Date:1/10/2020)... , ... January 10, 2020 , ... ... has announced that it will be attending the HIMSS (Healthcare Information and Management ... , HIMSS is the can’t-miss health information and technology event of the year, ...
(Date:1/8/2020)... ... 08, 2020 , ... Mirror Mirror Beauty Boutique ... of Memorial Readers’ Choice Awards. Located adjacent to Vitenas Cosmetic Surgery, the ... Memorial reflects Mirror Mirror Beauty Boutique’s commitment to the hottest noninvasive trends that ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... and services, today identified six trends that will significantly impact the point of ... “Arguably, the time shared between a provider and patient is the most important ...
(Date:1/7/2020)... Pa. (PRWEB) , ... January 07, 2020 , ... Iconic ... musical talent and being one of the most successful female artists of all time, ... started her first Las Vegas residency and shared in interviews her secrets to making ...
Breaking Medicine News(10 mins):